A Systematic Review and Narrative Synthesis of Health Economic Evaluations of Hepatocellular Carcinoma Screening Strategies
Many economic evaluations of hepatocellular carcinoma (HCC) screenings have been conducted; however, these vary substantially with regards to screening strategies, patient group, and setting. This review aims to report the current knowledge of the cost-effectiveness of screening and describe the published data. (Source: Value in Health)
Source: Value in Health - March 4, 2021 Category: International Medicine & Public Health Authors: Anh Le Tuan Nguyen, Hoa Thi Thu Nguyen, Kwang Chien Yee, Andrew J. Palmer, Christopher Leigh Blizzard, Barbara de Graaff Source Type: research

Minimizing Population Health Loss in Times of Scarce Surgical Capacity During the Coronavirus Disease 2019 Crisis and Beyond: A Modeling Study
Coronavirus disease 2019 has put unprecedented pressure on healthcare systems worldwide, leading to a reduction of the available healthcare capacity. Our objective was to develop a decision model to estimate the impact of postponing semielective surgical procedures on health, to support prioritization of care from a utilitarian perspective. (Source: Value in Health)
Source: Value in Health - March 4, 2021 Category: International Medicine & Public Health Authors: Benjamin Gravesteijn, Eline Krijkamp, Jan Busschbach, Geert Geleijnse, Isabel Retel Helmrich, Sophie Bruinsma, C éline van Lint, Ernest van Veen, Ewout Steyerberg, Kees Verhoef, Jan van Saase, Hester Lingsma, Rob Baatenburg de Jong, Value Based Operation Source Type: research

Editorial Board
(Source: Value in Health)
Source: Value in Health - February 26, 2021 Category: International Medicine & Public Health Source Type: research

Table of Contents
(Source: Value in Health)
Source: Value in Health - February 26, 2021 Category: International Medicine & Public Health Source Type: research

Copyright/Subscription
(Source: Value in Health)
Source: Value in Health - February 26, 2021 Category: International Medicine & Public Health Source Type: research

The Use of Decision Analytic Modeling in the Evaluation of Surgical Innovations: A Scoping Review
The main objective of this review was to map how decision analytic models are used in surgical innovation (in which research phase, with what aim) and to understand how challenges related to the assessment of surgical interventions are incorporated. (Source: Value in Health)
Source: Value in Health - February 25, 2021 Category: International Medicine & Public Health Authors: Mirre Scholte, Maroeska M. Rovers, Janneke P.C. Grutters Source Type: research

Disease Burden Attributable to the First Wave of COVID-19 in China and the Effect of Timing on the Cost-Effectiveness of Movement Restriction Policies
This study aims to estimate the health burden of the first wave of COVID-19 in China and the cost-effectiveness of early versus late implementation of MRPs to inform preparation for future waves. (Source: Value in Health)
Source: Value in Health - February 21, 2021 Category: International Medicine & Public Health Authors: Jidi Zhao, Huajie Jin, Xun Li, Jianguo Jia, Chao Zhang, Huijuan Zhao, Wuren Ma, Zhuozhu Wang, Yi He, Jimmy Lee, Donglan Zhang, Bo Yin, Weiwei Zheng, Haiyin Wang, Mark Pennington Source Type: research

How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine?
The potential health and economic value of a vaccine for coronavirus disease (COVID-19) is self-evident given nearly 2 million deaths, “collateral” loss of life as other conditions go untreated, and massive economic damage. Results from the first licensed products are very encouraging; however, there are important reasons why we will likely need second and third generation vaccines. Dedicated incentives and funding focused expl icitly on nurturing and advancing competing second and third generation vaccines are essential. (Source: Value in Health)
Source: Value in Health - February 18, 2021 Category: International Medicine & Public Health Authors: Adrian Towse, Kalipso Chalkidou, Isobel Firth, Hannah Kettler, Rachel Silverman Source Type: research

Joint Longitudinal Models for Dealing With Missing at Random Data in Trial-Based Economic Evaluations
In trial-based economic evaluation, some individuals are typically associated with missing data at some time point, so that their corresponding aggregated outcomes (eg, quality-adjusted life-years) cannot be evaluated. Restricting the analysis to the complete cases is inefficient and can result in biased estimates, while imputation methods are often implemented under a missing at random (MAR) assumption. We propose the use of joint longitudinal models to extend standard approaches by taking into account the longitudinal structure to improve the estimation of the targeted quantities under MAR. (Source: Value in Health)
Source: Value in Health - February 18, 2021 Category: International Medicine & Public Health Authors: Andrea Gabrio, Rachael Hunter, Alexina J. Mason, Gianluca Baio Source Type: research

Intraindividual Comparisons to Determine Comparative Effectiveness: Their Relevance for G-BA ’s Health Technology Assessments
Health technology assessments (HTA) rely on head-to-head comparisons. We searched for intraindividual comparisons (IIC) qualifying as head-to-head design to develop comparative evidence. (Source: Value in Health)
Source: Value in Health - February 17, 2021 Category: International Medicine & Public Health Authors: Julia Annabel Wagle, Jan-Paul Flacke, Dietrich Knoerzer, J örg Ruof, Sonja Merkesdal Source Type: research

Direct Medical Costs of Advanced Breast Cancer Treatment: A Real-World Study in the Southeast of The Netherlands
This study aims to provide a detailed account of the hospital resource use and associated costs of patients with advanced breast cancer in The Netherlands. (Source: Value in Health)
Source: Value in Health - February 13, 2021 Category: International Medicine & Public Health Authors: Paul Peter Schneider, Bram L. Ramaekers, Xavier Pouwels, Sandra Geurts, Khava Ibragimova, Maaike de Boer, Birgit Vriens, Yes van de Wouw, Marien den Boer, Manon Pepels, Vivianne Tjan-Heijnen, Manuela Joore Source Type: research

Nutrition Economics: Celebrating Cross-Disciplinary Collaboration
In some ways, economists and physicians make uneasy partners in the great enterprise of health economics. Economists ’ language is of constraints, budgets, costs, trade-offs, and optimization, whereas physicians focus on the science and art of healing. However, economists share much in common with evolutionary biologists and anthropologists working in the field of human nutrition. Evolutionary biologists talk of organisms facing hard constraints (“energy budgets”) and, in the case of humans, of the “expense” of running large brains (14.6 watts). (Source: Value in Health)
Source: Value in Health - February 11, 2021 Category: International Medicine & Public Health Authors: David Epstein Tags: Themed Section: Nutrition Economics Source Type: research

When Industrial Policies Conflict With Population Health: Potential Impact of Removing Food Subsidies on Obesity Rates
To model the potential impact on obesity of removing butter, cheese, and sugar subsidies in the Canary Islands. (Source: Value in Health)
Source: Value in Health - February 11, 2021 Category: International Medicine & Public Health Authors: Silvia Rodr íguez-Mireles, Beatriz G. López-Valcárcel, Lluís Serra-Majem Source Type: research

A Systematic Review of Cost-Effectiveness Studies of Interventions with a Personalized Nutrition Component in Adults
Important links between dietary patterns and diseases have been widely applied to establish nutrition interventions. However, knowledge about between-person heterogeneity regarding the benefits of nutrition intervention can be used to personalize the intervention and thereby improve health outcomes and efficiency. We performed a systematic review of cost-effectiveness analyses (CEAs) of interventions with a personalized nutrition (PN) component to assess their methodology and findings. (Source: Value in Health)
Source: Value in Health - February 10, 2021 Category: International Medicine & Public Health Authors: Milanne M.J. Galekop, Carin A. Uyl-de Groot, W. Ken Redekop Source Type: research

Past and Current Practice of Patient-Reported Outcome Measurement in Randomized Cancer Clinical Trials: A Systematic Review
In our systematic review, we assessed past and current practice of patient-reported outcome (PRO) measurement in cancer randomized, controlled trials (RCTs). (Source: Value in Health)
Source: Value in Health - February 9, 2021 Category: International Medicine & Public Health Authors: Johannes M. Giesinger, Fabio Efficace, Neil Aaronson, Melanie Calvert, Derek Kyte, Francesco Cottone, David Cella, Eva-Maria Gamper Source Type: research

Table of Contents
(Source: Value in Health)
Source: Value in Health - January 29, 2021 Category: International Medicine & Public Health Source Type: research

Copyright/Subscription
(Source: Value in Health)
Source: Value in Health - January 29, 2021 Category: International Medicine & Public Health Source Type: research

Editorial Board
(Source: Value in Health)
Source: Value in Health - January 29, 2021 Category: International Medicine & Public Health Source Type: research

The Dollar or Disease Burden: Caps on Healthcare Spending May Save Money, but at What “Cost” to Patients?
Various strategies to address healthcare spending and medical costs continue to be debated and implemented in the United States. To date, these efforts have failed to adequately contain the growth of healthcare cost. An alternative strategy that has elicited rising interest among policymakers is budget caps. As budget caps become more prevalent, it is important to identify which features are needed to ensure success, both in terms of cost reduction and health improvement. (Source: Value in Health)
Source: Value in Health - January 27, 2021 Category: International Medicine & Public Health Authors: Michael Ciarametaro, Katherine Houghton, David Wamble, Robert Dubois Source Type: research

Disability-Adjusted Life Years Averted Versus Quality-Adjusted Life Years Gained: A Model Analysis for Breast Cancer Screening
To quantify the impact of mammography-based screening on the quality of life, disability-adjusted life years (DALYs) averted or quality-adjusted life years (QALYs) gained can be used. We aimed to assess whether the use of DALYs averted or QALYs gained will lead to different cost-effective screening strategies. (Source: Value in Health)
Source: Value in Health - January 25, 2021 Category: International Medicine & Public Health Authors: Ma ša Davidović, Nadine Zielonke, Iris Lansdorp-Vogelaar, Nereo Segnan, Harry J. de Koning, Eveline AM. Heijnsdijk Source Type: research

Cost-Effectiveness Analysis of a Pharmacist-Led Medication Therapy Management Program: Hypertension Management
Uncontrolled hypertension is a common cause of cardiovascular disease, which is the deadliest and costliest chronic disease in the United States. Pharmacists are an accessible community healthcare resource and are equipped with clinical skills to improve the management of hypertension through medication therapy management (MTM). Nevertheless, current reimbursement models do not incentivize pharmacists to provide clinical services. We aim to investigate the cost-effectiveness of a pharmacist-led comprehensive MTM clinic compared with no clinic for 10-year primary prevention of stroke and cardiovascular disease events in pat...
Source: Value in Health - January 24, 2021 Category: International Medicine & Public Health Authors: Bob G. Schultz, Jessica Tilton, Julie Jun, Tiffany Scott-Horton, Danny Quach, Daniel R. Touchette Source Type: research

Attribute Selection for a Discrete Choice Experiment Incorporating a Best-Worst Scaling Survey
We present a case study in which a best-worst scaling case 1 (BWS-1) survey was used to guide attribute selection for a DCE. The case study ’s context was the decision making of professionals around the choice of augmentative and alternative communication (AAC) systems for children with limited natural speech. (Source: Value in Health)
Source: Value in Health - January 23, 2021 Category: International Medicine & Public Health Authors: Edward J.D. Webb, David Meads, Yvonne Lynch, Simon Judge, Nicola Randall, Juliet Goldbart, Stuart Meredith, Liz Moulam, Stephane Hess, Janice Murray Source Type: research

Assessing the Value of Cemiplimab for Adults With Advanced Cutaneous Squamous Cell Carcinoma: A Cost-Effectiveness Analysis
To evaluate the cost-effectiveness of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC) from a payer perspective in the United States. (Source: Value in Health)
Source: Value in Health - January 22, 2021 Category: International Medicine & Public Health Authors: Gerasimos Konidaris, Eleanor Paul, Andreas Kuznik, Sam Keeping, Chieh-I Chen, Medha Sasane, Yingxin Xu, Kokuvi Atsou, Dieter Ayers, Emily S. Ruiz, Nikhil I. Khushalani, Shannon Cope Source Type: research

Health State Utility Values in Schizophrenia: A Systematic Review and Meta-Analysis: Author ’s Reply
We thank the letter written by Neil et al for highlighting the importance of the Australian Quality of Life 4 dimensions instrument in the assessment of health-state utility values (HSUVs) in people with schizophrenia. (Source: Value in Health)
Source: Value in Health - January 21, 2021 Category: International Medicine & Public Health Authors: David Aceituno Source Type: research

Preferences for e-Mental Health Interventions in Germany: A Discrete Choice Experiment
Recent evidence suggests that e-mental health interventions can be effective at improving mental health but that there is still a notable hesitation among patients to use them. Previous research has revealed that they are perceived by patients as being less helpful than face-to-face psychotherapy. The reasons for this unfavorable perception are, however, not yet well understood. The aim of our study was to address this question by eliciting preferences for individual components of e-mental health interventions in a discrete choice experiment. (Source: Value in Health)
Source: Value in Health - January 20, 2021 Category: International Medicine & Public Health Authors: Elena A. Phillips, Sebastian F. Himmler, Jonas Schrey ögg Source Type: research

Late Pregnancy Ultrasound to Screen for and Manage Potential Birth Complications in Nulliparous Women: A Cost-Effectiveness and Value of Information Analysis
Fetal growth restriction is a major risk factor for stillbirth. A routine late-pregnancy ultrasound scan could help detect this, allowing intervention to reduce the risk of stillbirth. Such a scan could also detect fetal presentation and predict macrosomia. A trial powered to detect stillbirth differences would be extremely large and expensive. (Source: Value in Health)
Source: Value in Health - January 20, 2021 Category: International Medicine & Public Health Authors: Edward C.F. Wilson, David Wastlund, Alexandros A. Moraitis, Gordon C.S. Smith Source Type: research

A Value Framework for the Assessment of Diagnostic Technologies: A Proposal Based on a Targeted Systematic Review and a Multistakeholder Deliberative Process in Latin America
there are very few value frameworks (VFs) to assess health technologies that are focused on diagnostic tests; they usually do not reflect a multistakeholder process; and they are all developed in high-income countries. Our project performed a targeted systematic review, with the objective of proposing an evidence-based, up-to-date VF informed by a multinational multistakeholder group working in the health technology assessment (HTA) space. (Source: Value in Health)
Source: Value in Health - January 15, 2021 Category: International Medicine & Public Health Authors: Federico Augustovski, Veronica Alfie, Andrea Alcaraz, Sebasti án García Martí, Michael Drummond, Andrés Pichon-Riviere Source Type: research

Opioid Misuse: A Global Crisis
It important not to be complacent about the opioid crisis —it continues unabated and demands renewed and focused attention. Almost 450 000 Americans died of an opioid-related overdose between 1999 and 2018.1 In 2017, the US Department of Health and Human Services declared the opioid crisis a national public health emergency.2 Approximately 1 in 100 adult s in the United States have an active opioid-use disorder (OUD); 88% have not received any medication for treatment. Several studies have projected a grim outlook for the opioid epidemic in the United States; under status quo, another 480 000 people could die from fa...
Source: Value in Health - January 13, 2021 Category: International Medicine & Public Health Authors: John Hornberger, Jagpreet Chhatwal Tags: Themed Section: Opioid Misuse: A Global Crisis Source Type: research

Cost-Effectiveness of an Opioid Abuse –Prevention Program Using the Narcotics Information Management System in South Korea
To assess the cost-effectiveness of an opioid abuse –prevention program embedded in the Narcotics Information Management System (“the Network System to Prevent Doctor-Shopping for Narcotics”) in South Korea. (Source: Value in Health)
Source: Value in Health - January 13, 2021 Category: International Medicine & Public Health Authors: Siin Kim, Eunji Kim, Hae Sun Suh Source Type: research

Introduction to Themed Section on Opioid Misuse
It important not to be complacent about the opioid crisis —it continues unabated and demands renewed and focused attention. Almost 450 000 Americans died of an opioid-related overdose between 1999 and 2018.1 In 2017, the US Department of Health and Human Services declared the opioid crisis a national public health emergency.2 Approximately 1 in 100 adult s in the United States have an active opioid-use disorder (OUD); 88% have not received any medication for treatment. Several studies have projected a grim outlook for the opioid epidemic in the United States; under status quo, another 480 000 people could die from fa...
Source: Value in Health - January 13, 2021 Category: International Medicine & Public Health Authors: John Hornberger, Jagpreet Chhatwal Source Type: research

Health Technology Assessment With Diminishing Returns to Health: The Generalized Risk-Adjusted Cost-Effectiveness (GRACE) Approach
Cost-effectiveness analysis (CEA) embeds an assumption at odds with most economic analysis –that of constant returns to health in the creation of happiness (utility). We aim to reconcile it with the bulk of economic theory. (Source: Value in Health)
Source: Value in Health - January 12, 2021 Category: International Medicine & Public Health Authors: Darius N. Lakdawalla, Charles E. Phelps Source Type: research

Utility Decrements Associated With Diabetes and Related Complications: Estimates From a Population-Based Study in Germany
Health utility decrement estimates for diabetes and complications are needed for parametrization of simulation models that aim to assess the cost-utility of diabetes prevention and care strategies. Thisstudy estimates health utility decrements associated with diabetes and cardiovascular and microvascular complications from a cross-sectional population-based German study. (Source: Value in Health)
Source: Value in Health - January 11, 2021 Category: International Medicine & Public Health Authors: Michael Laxy, Jana Becker, Katharina K ähm, Rolf Holle, Annette Peters, Barbara Thorand, Lars Schwettmann, Florian M. Karl Source Type: research

Association Between Dual Trajectories of Opioid and Gabapentinoid Use and Healthcare Expenditures Among US Medicare Beneficiaries
This study examined the association between patients ’ opioid and gabapentinoid prescription filling/refilling trajectories and direct medical expenditures in US Medicare. (Source: Value in Health)
Source: Value in Health - January 11, 2021 Category: International Medicine & Public Health Authors: Lili Zhou, Sandipan Bhattacharjee, C. Kent Kwoh, Daniel C. Malone, Patrick J. Tighe, Gary M. Reisfield, Marion Slack, Debbie L. Wilson, Wei-Hsuan Lo-Ciganic Source Type: research

Health State Utility Values in Schizophrenia: A Systematic Review and Meta-Analysis: A Letter to the Editor
We are writing to inform readers of the results of 2 papers,1,2 referred to but not reported on in “Health State Utility Values in Schizophrenia: A Systematic Review and Meta-Analysis” by Aceituno and colleagues.3 Both papers employed the generic preference-based measure, the Assessment of Quality of Life (AQoL)-4D.4 (Source: Value in Health)
Source: Value in Health - January 7, 2021 Category: International Medicine & Public Health Authors: Amanda L. Neil, Vaughan J. Carr, Adriana G. Nevarez-Flores, Helen Herrman, Vera A. Morgan Source Type: research

Patient-Reported Outcomes as Independent Prognostic Factors for Survival in Oncology: Systematic Review and Meta-Analysis
Assessment of patient-reported outcomes (PROs) in oncology is of critical importance because it provides unique information that may also predict clinical outcomes. (Source: Value in Health)
Source: Value in Health - January 6, 2021 Category: International Medicine & Public Health Authors: Fabio Efficace, Gary S. Collins, Francesco Cottone, Johannes M. Giesinger, Kathrin Sommer, Amelie Anota, Michael Maia Schlussel, Paola Fazi, Marco Vignetti Source Type: research

Development and Validation of a Hospital Indicator of Activity-Based Costs for Injury Admissions
To develop a hospital indicator of resource use for injury admissions. (Source: Value in Health)
Source: Value in Health - January 6, 2021 Category: International Medicine & Public Health Authors: Teegwend é V. Porgo, Lynne Moore, Coralie Assy, Xavier Neveu, Catherine Gonthier, Simon Berthelot, Belinda J. Gabbe, Peter A. Cameron, Francis Bernard, Alexis F. Turgeon Source Type: research

An International Comparison of EQ-5D-5L and EQ-5D-3L for Use in Cost-Effectiveness Analysis
To estimate the impact of using EQ5D-5L (5L) compared with EQ5D-3L (3L) in cost-effectiveness analyses in 6 countries with 3L and 5L values: Germany, Japan, Korea, The Netherlands, China, and Spain. (Source: Value in Health)
Source: Value in Health - January 6, 2021 Category: International Medicine & Public Health Authors: Allan Wailoo, M ónica Hernández Alava, Stephen Pudney, Garry Barton, John O’Dwyer, Manuel Gomes, Lisa Irvine, David Meads, Zia Sadique Source Type: research

Assessing the Added Therapeutic Benefit of Ultra-Expensive Drugs
We examined the added therapeutic benefit of the most expensive drugs prescribed to Medicare Part D beneficiaries in the United States. (Source: Value in Health)
Source: Value in Health - January 5, 2021 Category: International Medicine & Public Health Authors: Michael J. DiStefano, So-Yeon Kang, Farah Yehia, Christian Morales, Gerard F. Anderson Source Type: research

Editorial Board
(Source: Value in Health)
Source: Value in Health - January 1, 2021 Category: International Medicine & Public Health Source Type: research

Table of Contents
(Source: Value in Health)
Source: Value in Health - January 1, 2021 Category: International Medicine & Public Health Source Type: research

Copyright/Subscription
(Source: Value in Health)
Source: Value in Health - January 1, 2021 Category: International Medicine & Public Health Source Type: research

Instructions for Authors
As the official journal of ISPOR, Value in Health provides a forum for researchers, healthcare decision makers, and policy makers to apply health economics and outcomes research into healthcare decisions. The goal of Value in Health is to advance scholarly and public dialogue about the assessment of value in health and healthcare. (Source: Value in Health)
Source: Value in Health - January 1, 2021 Category: International Medicine & Public Health Source Type: research

International Reference Pricing for Prescription Drugs in the United States: Administrative Limitations and Collateral Effects
Many countries use international (or external) reference pricing —benchmarking prices against those in other countries—to manage spending on prescription drugs. By contrast, the United States (US) allows manufacturers to set drug prices freely. In December 2019, a major bill passed the House of Representatives that would introduce international reference pric ing to reduce US drug spending. In September 2020, President Trump issued an executive order to apply international reference pricing for drugs purchased under Medicare. (Source: Value in Health)
Source: Value in Health - December 31, 2020 Category: International Medicine & Public Health Authors: Leah Z. Rand, Aaron S. Kesselheim Source Type: research

Engaging the Voices of Children: A Scoping Review of How Children and Adolescents Are Involved in the Development of Quality-of-Life –Related Measures
Patient-reported outcomes are increasingly recommended to guide patient care, develop and evaluate interventions, and modify health systems. However, not enough is known about whether and how children and adolescents, as “experts” in their own health and quality of life (QoL), are being engaged in the development of instruments. Our goals in this review were (1) to identify all QoL-related instruments that have included children and/or adolescents in the development of questionnaire content, including identifica tion of themes and items; and (2) to report how this was done; and (3) to highlight those that used ...
Source: Value in Health - December 28, 2020 Category: International Medicine & Public Health Authors: Jessica Willis, Dena Zeratkaar, Julia ten Hove, Peter Rosenbaum, Gabriel M. Ronen Source Type: research

Evaluating the Cost-Effectiveness of Changes to the Surveillance Intervals in the UK Abdominal Aortic Aneurysm Screening Programme
To investigate the safety and cost-effectiveness of lengthening the time between surveillance ultrasound scans in the UK Abdominal Aortic Aneurysm (AAA) Screening Programme. (Source: Value in Health)
Source: Value in Health - December 23, 2020 Category: International Medicine & Public Health Authors: Michael J. Sweeting, John Marshall, Matthew Glover, Akhtar Nasim, Matthew J. Bown Source Type: research

Friction Costs and the Chain of Vacancies Problem: A Novel Vacancy Multiplier Solution
A key criticism of applying the friction cost approach (FCA) to productivity cost estimation is its focus on a single friction period. A more accurate estimate of the friction cost of worker absence requires consideration of the chain of secondary vacancies arising from the opening of a new primary vacancy. Currently, empirical evidence on this is almost absent. We suggest an original approach to empirically estimate productivity costs that include a chain of secondary vacancies. (Source: Value in Health)
Source: Value in Health - December 22, 2020 Category: International Medicine & Public Health Authors: Paul Hanly, Marta Ortega-Ortega, Linda Sharp Source Type: research

Cost-Effectiveness Analysis of Transcatheter Arterial Embolization Techniques for the Treatment of Gastrointestinal Bleeding in the United States
Gastrointestinal (GI) bleeding is a common medical emergency associated with significant mortality. Transcatheter arterial embolization first was introduced by Rosch et  al as an alternative to surgery for upper GI bleeding. The clinical success in patients with GI bleeding treated with transcatheter arterial embolization previously has been reported. However, there are no cost-effectiveness analyses reported to date. Here we report cost-effectiveness analysis of N-butyl 2-cyanoacrylate glue (NBCA) and ethylene-vinyl alcohol copolymer (Onyx) versus coil (gold standard) for treatment of GI bleeding from a healthcare pa...
Source: Value in Health - December 22, 2020 Category: International Medicine & Public Health Authors: Negin Razavilar, Javad Moradpour Taleshi Source Type: research

Cost-Effectiveness of Targeted Genetic Testing for Breast and Ovarian Cancer: A Systematic Review
Targeted genetic testing is a tool to identify women at increased risk of gynaecological cancer. (Source: Value in Health)
Source: Value in Health - December 19, 2020 Category: International Medicine & Public Health Authors: Andreas Koldehoff, Marion Danner, Daniele Civello, Kerstin Rhiem, Stephanie Stock, Dirk M üller Source Type: research

A Patient-Centric Tool to Facilitate Goal Attainment Scaling in Neurogenic Bladder and Bowel Dysfunction: Path to Individualization
People with neurogenic bladder and/or bowel dysfunction experience diverse challenges that can be difficult to evaluate with standardized outcome measures. Goal attainment scaling (GAS) is an individualized, patient-centric outcome measure that enables patients/caregivers to identify and track their own treatment goals. Because creating goals de novo can be cumbersome, we aimed to develop a neurogenic bladder/bowel dysfunction goal menu to facilitate goal attainment scaling uptake and use. (Source: Value in Health)
Source: Value in Health - December 19, 2020 Category: International Medicine & Public Health Authors: Jimena Goldstine, Kari Knox, Joke Beekman, Hanny Cobussen-Boekhorst, Alessio Conti, Mikel Gray, Gary Inglese, Amanda England, Gianna Rodriguez, Justin Stanley, Stephanie Vaughn, Susan E. Howlett, Kenneth Rockwood Source Type: research

Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in the Dutch National Influenza Prevention Program
The objective was to estimate the incremental break-even price of QIV over TIV at a threshold of €20 000 per quality-adjusted life-year (QALY). (Source: Value in Health)
Source: Value in Health - December 18, 2020 Category: International Medicine & Public Health Authors: Florian Zeevat, Pascal Cr épey, F. Christiaan K. Dolk, Arjan J. Postma, Vidya N.A. Breeveld-Dwarkasing, Maarten J. Postma Source Type: research